Inveltys Suspension
Product Images NDC 0065-9307

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Inveltys (NDC 0065-9307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alcon Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Sample-carton (300074556)

Sample-carton (300074556)
This is a description of the ophthalmic suspension medication "INVELTYS" containing loteprednol etabonate. Each milliliter (mL) of the suspension includes 10 mg (1%) of loteprednol etabonate along with inactive ingredients such as Glycerin, Poloxamer 407, and Sodium Chloride. The preservative used is Benzalkonium Chloride 0.01%. It is manufactured by Alcon Laboratories, Inc. in Fort Worth, Texas, USA. The product is stored upright at 15°C to 25°C and should not be frozen. The dosage should be as per the prescribing information provided. This ophthalmic suspension is specifically for topical application in the eye and is a professional sample not meant for retail sale.*
FDA Label Image

28ml-carton (300074557)

28ml-carton (300074557)
This is a detailed description for the prescription medication with the NDC code 0065-9307-04. It is a sterile ophthalmic suspension with the active ingredient loteprednol etabonate. Each mL of Inveltys Ophthalmic Suspension contains 10 mg (1%) of loteprednol etabonate. The inactives include Glycerin, Sodium Citrate, Pluronic 407, Sodium Chloride, Disodium EDTA, Citric Acid, and Water for Injection. The preservative used is Benzalkonium Chloride at a concentration of 0.01%. It is advised to store the medication upright at 15°C (59°F to 77°F) and not to freeze it. Manufactured by Alcon Laboratories, Inc. in Fort Worth, Texas, USA. It also warns not to use the medication in the eye and to check for tamper evidence before use.*
FDA Label Image

2.8ml-label (300074563)

2.8ml-label (300074563)
This is a prescription for NIX/ELT YS^NDC0065-9307-04, a 1% oteprednol etabonate ophthalmic suspension in a 2.8mL sterile container manufactured by Alcon Laboratories, located in Fort Worth, Texas.*
FDA Label Image

Sample-label (300074565)

Sample-label (300074565)
This is a sample of NWVELTYS® NDC00659307-05, a 1% ophthalmic suspension of oteprednol etabonate in a 2.8mL sterile solution by Alcon Laboratories, Inc. located in Fort Worth, Texas 76134 USA. It is used for ophthalmic purposes.*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
This text provides data on the percentage of patients with complete resolution of pain (Grade 0) after using INVELTYS BID on different days (Day 4, Day 8, and Day 15) compared to a Vehicle treatment group. For Day 4, the percentage is 36%, for Day 8 it is 25%, and for Day 15 it is 8%. The study includes 386 patients in the INVELTYS BID group and 385 patients in the Vehicle group.*
FDA Label Image

Figure A (Figure A)

Figure A (Figure A)
FDA Label Image

Figure B (Figure B)

Figure B (Figure B)
FDA Label Image

Figure C (Figure C)

Figure C (Figure C)
FDA Label Image

Figure D (Figure D)

Figure D (Figure D)
FDA Label Image

Figure E (Figure E)

Figure E (Figure E)
FDA Label Image

Molecule (Mol)

Molecule (Mol)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.